Cargando…
Glycosylation is a key in SARS-CoV-2 infection
SARS-CoV-2 causes the respiratory syndrome COVID-19 and is responsible for the current pandemic. The S protein of SARS-CoV-2-mediating virus binding to target cells and subsequent viral uptake is extensively glycosylated. Here we focus on how glycosylation of both SARS-CoV-2 and target cells crucial...
Autores principales: | Reis, Celso A., Tauber, Rudolf, Blanchard, Véronique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140746/ https://www.ncbi.nlm.nih.gov/pubmed/34023935 http://dx.doi.org/10.1007/s00109-021-02092-0 |
Ejemplares similares
-
Glycosylation in SARS-CoV-2 variants: A path to infection and recovery
por: Aloor, Arya, et al.
Publicado: (2022) -
Glycosylation of SARS-CoV-2: structural and functional insights
por: Shajahan, Asif, et al.
Publicado: (2021) -
Glycosylation is key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2
por: Ropón-Palacios, Georcki, et al.
Publicado: (2022) -
Principles of SARS-CoV-2 glycosylation
por: Chawla, Himanshi, et al.
Publicado: (2022) -
The glycosylation in SARS-CoV-2 and its receptor ACE2
por: Gong, Yanqiu, et al.
Publicado: (2021)